SCHEMBL9040647

SCHEMBL9040647

Nc1cccc(-c2ncc3[nH]c4c(c3n2)CCCC4)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
ATAD2 Q6PL18 1/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAP4K4 O95819 3/20 0.36
EGFR P00533 6/20 0.36
ABL1 P00519 1/20 0.36
ABL2 P42684 1/20 0.36
METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045521 0.85 EGFR (0.43) KDM4EALDH1A1HPGDLMNAMAPT
SCHEMBL9041707 0.85 HPGDS (0.41) KDM4EALDH1A1LMNAMAPTNPC1
SCHEMBL9044118 0.85 EGFR (0.43) BRD4KDM4EALDH1A1HPGDLMNA
SCHEMBL9041822 0.85 EGFR (0.43) ALDH1A1MEN1LMNAMAPTKMT2A
SCHEMBL9040418 0.84 KDM4E (0.40) KDM4EALDH1A1LMNANPC1RAB9A
SCHEMBL9043615 0.82 IDO1 (0.40) KDM4EALDH1A1HPGDMEN1LMNA
SCHEMBL8774614 0.82 GAA (0.49) BRD4KDM4EALDH1A1HPGDMEN1
SCHEMBL9041842 0.81 FGFR2 (0.44) KDM4EALDH1A1HPGDMEN1LMNA
SCHEMBL9042579 0.76 MAOA (0.41) BRD4KDM4EALDH1A1MEN1MAPT
SCHEMBL9043690 0.74 CUL4A (0.43) KDM4EALDH1A1HPGDMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0738717-A1 Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines NEUROGEN CORPORATION (US) 1996-10-23 EP claimed
EP-0552237-A1 CERTAIN CYCLOALKYL AND AZACYCLOALKYL PYRROLOPYRIMIDINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1993-07-28 EP claimed
WO-1992006094-A1 CERTAIN CYCLOALKYL AND AZACYCLOALKYL PYRROLOPYRIMIDINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1992-04-16 WO claimed
US-5585490-A DIANGOSIS AND TREATMENT OF ANXIETY, SLEEP, AND SEIZURE DISORDERS NEUROGEN CORPORATION (US) 1996-12-17 US disclosed
EP-0738717-A1 Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines NEUROGEN CORPORATION (US) 1996-10-23 EP disclosed